Suppr超能文献

新型非侵入性蛋白质和肽类药物递送方法。

Novel non-invasive protein and peptide drug delivery approaches.

作者信息

Wallis L, Kleynhans E, Toit T Du, Gouws C, Steyn D, Steenekamp J, Viljoen J, Hamman J

机构信息

Centre of Excellence for Pharmaceutical Sciences, North-West University, Private Bag X6001, Potchefstroom, 2520, South Africa.

出版信息

Protein Pept Lett. 2014;21(11):1087-101. doi: 10.2174/0929866521666140807112148.

Abstract

Protein and peptide based therapeutics are typically administered by injection due to their poor uptake when administered via enteral routes of drug administration. Unfortunately, chronic administration of these drugs through multiple injections presents certain patient related problems and it is difficult to mimic the normal physiological release patterns via this mode of drug administration. A need therefore exists to non-invasively deliver these drugs by means of alternative ways such as via the oral, pulmonary, nasal, transdermal and buccal administration routes. Although some attempts of needle free peptide and protein drug delivery have progressed to the clinical stage, relatively limited success has been achieved in terms of commercially available products. Despite the low frequency of clinical breakthroughs with noninvasive protein drug delivery this far, it remains an active research area with renewed interest not only due to its improved therapeutic potential, but also due to the attractive commercial outcomes it offers. It is the aim of this review article to reflect on the main strategies investigated to overcome the barriers against effective systemic protein drug delivery in different routes of drug administration. Approaches based on chemical modifications and pharmaceutical technologies are discussed with reference to examples of drugs and devices that have shown potential, while attempts that have failed are also briefly outlined.

摘要

基于蛋白质和肽的治疗药物通常通过注射给药,因为经肠内给药途径给药时它们的吸收较差。不幸的是,通过多次注射长期给药会带来某些与患者相关的问题,并且通过这种给药方式很难模拟正常的生理释放模式。因此,需要通过替代方式,如口服、肺部、鼻腔、透皮和颊部给药途径,以非侵入性方式递送这些药物。尽管一些无针肽和蛋白质药物递送的尝试已进入临床阶段,但在商业可用产品方面取得的成功相对有限。尽管到目前为止非侵入性蛋白质药物递送的临床突破频率较低,但它仍然是一个活跃的研究领域,不仅因其改善的治疗潜力而重新受到关注,还因其提供的有吸引力的商业成果。这篇综述文章的目的是思考为克服不同给药途径中有效全身蛋白质药物递送的障碍而研究的主要策略。结合已显示出潜力的药物和装置实例,讨论了基于化学修饰和制药技术的方法,同时也简要概述了失败的尝试。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验